Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept
- PMID: 11599520
- PMCID: PMC88444
- DOI: 10.1128/JCM.39.10.3810-3811.2001
Prediction of enterococcal imipenem susceptibility using ampicillin or penicillin MICs: more evidence for a class concept
Figures
Comment on
-
Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.J Clin Microbiol. 2001 Jul;39(7):2729-31. doi: 10.1128/JCM.39.7.2729-2731.2001. J Clin Microbiol. 2001. PMID: 11427608 Free PMC article.
References
-
- Clissold S P, Todd P A, Campoli-Richards D M. Imipenem/cilastatin: a review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs. 1987;33:183–241. - PubMed
-
- Donabedian H, Freimer E H. Pathogenesis and treatment of endocarditis. Am J Med. 1985;78(Suppl. 6A):127–132. - PubMed
-
- Eron L J. Imipenem/cilastatin therapy of bacteremia. Am J Med. 1985;78(Suppl. 6A):95–99. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
